Compare VEEV & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VEEV | STE |
|---|---|---|
| Founded | 2007 | 1985 |
| Country | United States | United States |
| Employees | N/A | 3700 |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.9B | 24.4B |
| IPO Year | 2013 | 2018 |
| Metric | VEEV | STE |
|---|---|---|
| Price | $195.84 | $231.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 6 |
| Target Price | ★ $283.26 | $275.20 |
| AVG Volume (30 Days) | ★ 2.2M | 985.6K |
| Earning Date | 05-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.06% |
| EPS Growth | 34.16 | ★ 62.73 |
| EPS | 3.96 | ★ 5.69 |
| Revenue | $1,104,081,000.00 | ★ $5,459,515,000.00 |
| Revenue This Year | $13.64 | $9.88 |
| Revenue Next Year | $12.67 | $6.32 |
| P/E Ratio | $49.59 | ★ $41.95 |
| Revenue Growth | ★ 28.05 | 6.24 |
| 52 Week Low | $168.14 | $204.90 |
| 52 Week High | $310.50 | $269.44 |
| Indicator | VEEV | STE |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 30.53 |
| Support Level | $169.92 | $223.10 |
| Resistance Level | $288.00 | $231.27 |
| Average True Range (ATR) | 7.26 | 5.22 |
| MACD | 3.71 | -1.32 |
| Stochastic Oscillator | 71.29 | 4.75 |
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.